EFPIA - NEWSLETTER

EFPIA Newsletter 29 November 2018

News

27 November 2018 EFPIA notes with concern the ENVI Committee’s adoption of the Compromise Amendments on its...

The proposal to introduce an export manufacturing waiver to the SPC regulation sends a signal to the world that Europe...

26 November 2018 EFPIA response to European Council’s decision to support the Brexit withdrawal agreement

Our hope is that the deal is ratified and then immediate and intense focus is given to regulation and supply of medicines...

26 November 2018 Health industries call for a rapid adoption of Horizon Europe, its missions and partnerships...

The six undersigned European health industry associations are ambitious about a healthier future for the European citizens,...

29 November 2018 Stronger together for a healthier Europe

The challenges faced by patients and our healthcare systems are such that no one sector has all the answers. For a healthier...

Blogs

29 November 2018 Protecting the Spark, Avoiding the Storm

Every new treatment, every transformational shift in the outlook for patients starts with the spark of an idea

29 November 2018 Fostering the adoption of new clinical trial design supported by digital tools

Our ambition is to improve Europe’s access to innovative medicines and to contribute to a healthier future for Europe...

27 November 2018 Horizon Europe and its institutional partnerships can make Europe unique again

In the seventh EFPIA manifesto blog, we show how an institutional public private partnership that would enable new “radical...

Events

04 DEC 2018

EBE 7th Annual regulatory Conference London, UK

Delivering the promises of advanced therapies to patients requires marketing authorisation as well as successful outcomes...

Learn more →

12 FEB 2019

22102018 Data Transparency Conference Brussels

Demystifying Clinical Data Transparency: Lessons learnt so far

Learn more →

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶